Labcorp Holdings Inc. (LH) Debt to Assets Ratio: 0.39%
The debt to assets ratio for Labcorp Holdings Inc. (LH) is 0.39% as of Sunday, June 14, 2026.
LH Debt to Assets Ratio Metrics
DEBT TO ASSETS RATIO
0.39%
LH Competitors' Debt to Assets Ratio
| NAME | MARKET CAP | DEBT TO ASSETS RATIO |
|---|---|---|
| Labcorp Holdings Inc. (LH) | $21.83B | 0.39% |
| Mettler-Toledo International Inc. (MTD) | $22.86B | 0.63% |
| BioNTech SE (BNTX) | $22.90B | 0.01% |
| United Therapeutics Corporation (UTHR) | $23.17B | 0.00% |
| Waters Corporation (WAT) | $23.17B | 0.29% |
| Moderna, Inc. (MRNA) | $19.80B | 0.16% |
| Veeva Systems Inc. (VEEV) | $25.92B | 0.01% |
| Hologic, Inc. (HOLX) | $16.97B | 0.29% |
| DexCom, Inc. (DXCM) | $29.08B | 0.22% |
| Biogen Inc. (BIIB) | $29.53B | 0.24% |
Leverage Ratios Comparison
Debt/Assets
0.4%
Debt/Equity
0.84
Current Ratio
1.42
Interest Coverage
6.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
- Debt/Assets: Shows % of assets funded by creditors (bounded 0-100%)
- Debt/Equity: Shows debt relative to shareholder investment (can exceed 100%)
- Both measure leverage but from different perspectives
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Labcorp Holdings Inc. Debt to Assets Ratio Formula & Definition
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Labcorp Holdings Inc. Debt to Assets Ratio FAQ
- What is the debt to assets ratio for Labcorp Holdings Inc. (LH)?
- The debt to assets ratio for LH stock is 0.39%.
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter